Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin k antagonists: Results of epica study on the behalf of FCSA (italian federation of anticoagulation clinics)

Thrombosis and Haemostasis

Volumn 107, Issue 6, 2012, Pages 1100-1106

  Poli, Daniela ^a   Antonucci, Emilia ^b   Zanazzi, Maria ^a   Grifoni, Elisa ^b   Testa, Sophie ^c   Ageno, Walter ^d   Palareti, Gualtiero ^e  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c CREMONA HOSPITAL   (Italy)

^d UNIVERSITY OF INSUBRIA   (Italy)

^e UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Bleeding; Elderly; Glomerular filtration rate; VKA treatment

Indexed keywords

ANTIVITAMIN K; CREATININE;

AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CHRONIC KIDNEY DISEASE; DEATH; EMBOLISM; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HUMAN; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; VENOUS THROMBOEMBOLISM;

AGE FACTORS; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; BLOOD COAGULATION; CHRONIC DISEASE; FEMALE; GLOMERULAR FILTRATION RATE; HEMORRHAGE; HUMANS; INCIDENCE; ITALY; KIDNEY; KIDNEY DISEASES; MALE; ODDS RATIO; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM; VITAMIN K;

EID: 84861754446     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH11-10-0721     Document Type: Article

References (36)

1. Mant J, Hobbs FD, Fletcher K, et al.; Midland Research Practices Network (Mid-ReC) Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007; 370: 493-503.
2. Olesen JB, Lip GY, Lindhardsen J, et al. Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a 'real world' nationwide cohort study. Thromb Haemost 2011; 106: 739-749.
3. Douville P, Martel AR, Talbot J, et al. Impact of age on glomerular filtration estimates. Nephrol Dial Transplant 2009; 24: 97-103.
4. Pereira BJ. Introduction: new perspectives in chronic renal insufficiency. Am J Kidney Dis 2000; 36: S1-S3.
5. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117: e25-e146.
6. Beyth RJ, Quinn LM, Landefeld CS. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med 1998; 105: 91-99.
7. Gage BF, Yan Y, Milligan PE, et al. Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J 2006; 151: 713-719.
8. Pisters R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010; 138: 1093-1100.
9. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creati-nine. Nephron 1976; 16: 31-41.
10. Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of at-rial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 2010; 12: 1360-1342.
11. You JJ, Singer DE, Howard PA, et al. Antithrombotic Therapy for Atrial Fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e531S-e575S.
12. Levey AS, Bosch J P, Lewis JB, et al. A more accurate method to estimate glomeru-lar filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease study group. Ann Intern Med 1999; 130: 461-470.
13. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254.
14. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
15. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266.
16. Gouin-Thibault I, Pautas E, Mahé I, et al. Is Modification o f Diet in Renal Disease formula similar to Cockcroft-Gault formula to assess renal function in elderly hospitalized patients treated with low-molecular-weight heparin? J Gerontol A Biol Sci Med Sci 2007; 62: 1300-1305.
17. rd. Continuing the use of the Cockcroft-Gault equation for drug dosing in patients with impaired renal function. Clin Pharmacol Ther 2009; 86: 468-470.
18. Poli D, Antonucci E, Testa S, et al. Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation. Circulation 2011; 124: 824-829.
19. Tripodi A, Chantarangkul V, Akkawat B, et al. A partial factor V deficiency in anti-coagulated lyophilized plasmas has been identified as a cause of the international normalized ratio discrepancy in the external quality assessment scheme. Thromb Res 1995; 78: 283-292.
20. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2002; 26: S5-S20.
21. Rosendaal FR, Cannegieter SC, van der Meer FJM, et al. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993; 69: 236-239.
22. Palareti G, Leali N, Coccheri S, et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 1996; 348: 423-428.
23. Palareti G, Hirsh J, Legnani C, et al. Oral anticoagulation treatment in the elderly: a nested, prospective, case-control study. Arch Intern Med 2000; 160: 470-478.
24. Garcia DA, Lopes RD, Hylek EM. New-onset atrial fibrillation and warfarin initiation: high risk periods and implications for new antithrombotic drugs. Thromb Haemost 2010; 104: 1099-1105.
25. Duncan L, Heathcote J, Djurdjev O, et al. Screening for renal disease using serum creatinine: who are we missing? Nephrol Dial Transplant 2001; 16: 1042-1046.
26. Swedko PJ, Clark HD, Paramsothy K, et al. Serum creatinine is an inadequate screening test for renal failure in elderly patients. Arch Intern Med 2003; 163: 356-360.
27. Rimon E, Kagansky N, Cojocaru L, et al. Can creatinine clearance be accurately predicted by formulae in octogenarian in-patients? QJM 2004; 97: 281-287.
28. Pedone C, Corsonello A, Incalzi RA; GIFA Investigators. Estimating renal function in older people: a comparison of three formulas. Age Ageing 2006; 35: 121-126.
29. Nygaard HA, Naik M, Ruths S, et al. Clinically important renal impairment in various groups of old persons. Scand J Prim Health Care 2004; 22: 152-156.
30. Michels WM, Grootendorst DC, Verduijn M, et al. Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol 2010; 5: 1003-1009.
31. Corsonello A, Pedone C, Lattanzio F, et al. Chronic kidney disease and 1-year survival in elderly patients discharged from acute care hospitals: a comparison of three glomerular filtration rate equations. Nephrol Dial Transplant 2011; 26: 360-364.
32. Falga C, Capdevila JA, Soler S, et al. Clinical outcome of patients with venous thromboembolism and renal insufficiency: Findings from the RIETE registry. Thromb Haemost 2007; 98: 771-776.
33. Lip GY, Andreotti F, Fauchier L, et al. Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis. Thromb Haemost 2011; 106: 997-1011.
34. Monreal M, Falgá C, Valle R, et al. Venous thromboembolism in patients with renal insufficiency: findings from the RIETE Registry. Am J Med 2006; 119: 1073-1079.
35. Melloni C, Peterson ED, Chen AY, et al. Cockcroft-Gault versus modification of diet in renal disease: importance of glomerular filtration rate formula for classification of chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol 2008; 51: 991-996.
36. Roberts GW, Ibsen PM, Schiøler CT. Modified diet in renal disease method overestimates renal function in selected elderly patients. Age Ageing 2009; 38: 698-703.